Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease. | Allergy | 2022 | 35108405 | PubTator, text mining | PubMed |
| IL10 trains macrophage profibrotic function after lung injury. | Am J Physiol Lung Cell Mol Physiol | 2022 | 35107021 | PubTator, text mining | PubMed |
| Role of the S100 protein family in rheumatoid arthritis. | Arthritis Res Ther | 2022 | 35101111 | PubTator, text mining | PubMed |
| Loss of STING expression is prognostic in non-small cell lung cancer. | J Surg Oncol | 2022 | 35099823 | PubTator, text mining | PubMed |
| Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy. | SAGE Open Med | 2022 | 35096390 | PubTator, text mining | PubMed |
| Identification of a CD4+ T cell line with Treg-like activity. | Hum Immunol | 2022 | 35094878 | PubTator, text mining | PubMed |
| Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation. | Kidney Int | 2022 | 35090879 | PubTator, text mining | PubMed |
| Fluid Flow Stimulation Modulates Expression of S100 Genes in Normal Breast Epithelium and Breast Cancer. | Cell Mol Bioeng | 2022 | 35087607 | PubTator, text mining | PubMed |
| Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives. | J Inflamm Res | 2022 | 35087284 | PubTator, text mining | PubMed |
| SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus. | J Immunol | 2022 | 35082161 | PubTator, text mining | PubMed |
| Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. | Mol Neurodegener | 2022 | 35073950 | PubTator, text mining | PubMed |
| Molecular Mechanisms Leading from Periodontal Disease to Cancer. | Int J Mol Sci | 2022 | 35055157 | PubTator, text mining | PubMed |
| Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics. | Membranes (Basel) | 2022 | 35054611 | PubTator, text mining | PubMed |
| Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities. | Cancers (Basel) | 2022 | 35053509 | PubTator, text mining | PubMed |
| A Special Network Comprised of Macrophages, Epithelial Cells, and Gut Microbiota for Gut Homeostasis. | Cells | 2022 | 35053422 | PubTator, text mining | PubMed |
| Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury. | Stem Cell Res Ther | 2022 | 35033181 | PubTator, text mining | PubMed |
| Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma. | Sci Rep | 2022 | 35027623 | PubTator, text mining | PubMed |
| Future of Therapy for Inborn Errors of Immunity. | Clin Rev Allergy Immunol | 2022 | 35020169 | PubTator, text mining | PubMed |
| Accounting for B-cell Behavior and Sampling Bias Predicts Anti-PD-L1 Response in Bladder Cancer. | Cancer Immunol Res | 2022 | 35013004 | PubTator, text mining | PubMed |
| The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. | Int J Mol Sci | 2022 | 35008915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=44